ioannis Batsis - MD - General Hospital of Thessaloniki "George PAPANIKOLAOU" | LinkedIn
Corrigendum to “Hematopoietic Stem Cell Mobilization for Gene Therapy of Adult Patients With Severe β-Thalassemia: Results of Clinical Trials Using G-CSF or Plerixafor in Splenectomized and Nonsplenectomized Subjects”: Molecular Therapy
Positive impact of brentuximab vedotin on overall survival of patients with classical Hodgkin lymphoma who relapse or progress after autologous stem cell transplantation: A nationwide analysis - Tsirigotis - 2018 - Hematological
Ioannis Batsis - CEO - GEOTHERMIKI S.A | LinkedIn
Ioannis Batsakis - Owner - BATSIS | LinkedIn
PDF) Allogeneic Hematopoietic Cell Transplantation in Patients With Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria Clones: Time for a Change
Centro Ellenico di Milano - Kreu | Facebook
Clinics In Oncology | Home :: Remedy Publications LLC
PDF) G-CSF–primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs | Evangelia Yannaki - Academia.edu
Ioannis Batsis's research works | Chania General Hospital (St. George), Chaniá and other places
Frontiers | Risk Factors and Outcomes of Klebsiella pneumoniae Infection Before and After Allogeneic Hematopoietic Cell Transplantation | Medicine